Cantoblanco, Spain

Antonio Morreale De León

This inventor holds 3 USPTO granted patents and 1 published patent application and 3 EPO patents. Top assignees: Consejo Superior De Investigaciones Cientificas, Universidad Autónoma De Madrid. Active years: 2012-2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Antonio Morreale De León. Retrieved from https://idiyas.com/inventor/antonio-morreale-de-león

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 8.7

ph-index = 1


Location History:

  • Cantoblanco, ES (2012 - 2014)
  • Madrid, ES (2015)

Company Filing History:


Years Active: 2012-2015

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Antonio Morreale De León

Introduction

Antonio Morreale De León is a renowned inventor based in Cantoblanco, Spain. With an impressive portfolio that includes two patents, he is making significant contributions to the field of pharmaceutical research. His work primarily focuses on developing compounds that have therapeutic applications, particularly in the realm of antitumor treatment.

Latest Patents

Antonio's most recent patent is a groundbreaking compound that can inhibit UBC13-UEV interactions. This invention relates to a chemical structure where specific radicals and groups play critical roles in its function. The compound is aimed at producing pharmaceutical compositions that can be utilized for antitumor therapy and for treating diseases related to metabolic pathways involving the UBC13 enzyme and transcriptional factor NF-κB, as well as pathways involving PCNA or RAD6.

Career Highlights

Antonio Morreale De León is affiliated with the Consejo Superior de Investigaciones Científicas, where he conducts valuable research in pharmacology and medicinal chemistry. His dedication to innovation in biochemistry and his keen insight into molecular interactions have propelled him into the spotlight within the scientific community.

Collaborations

In his pursuit of scientific advancement, Antonio collaborates with fellow researchers including Timothy Thomson Okatsu and Johanna Scheper Sigmund. These collaborations foster an innovative environment that enhances research outcomes and drives the development of new therapeutic solutions.

Conclusion

Antonio Morreale De León's contributions to pharmaceutical inventions reflect his commitment to addressing critical health challenges through innovation. His work exemplifies the profound impact that dedicated inventors can have on society, particularly in the fields of medicine and biochemistry. With his ongoing research and collaboration, the future holds promise for further breakthroughs in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…